The Dutch bid for the European Medicines Agency
11-07-2017 | 13:00
Commitment, continuity, connectivity and community – those are the keywords in the Dutch bid for the EMA.
2nd Edition of MEB Regulatory Science Magazine released
15-06-2017 | 16:00
Today, the 2nd edition of the Regulatory Science Magazine was released. This online magazine, produced by the Medicines...
Assessment criteria for combination packages policy established
15-06-2017 | 15:00
The Medicines Evaluation Board (MEB) has described the terms and conditions which are to be used to assess applications for...
MEB Annual Report: a leading player in Europe again in 2016
08-06-2017 | 09:00
The Medicines Evaluation Board (MEB) was one of the leading players in Europe in the field of medicine assessment and...
New legal EudraVigilance obligations as of 22 November 2017
06-06-2017 | 13:00
As of 22 November 2017 new obligations in respect of signal management and reporting of suspected adverse reactions (ADRs) will...
Eric Boersma sworn in as new MEB Member
02-06-2017 | 10:00
Mr Prof H. (Eric) Boersma was sworn in as a new member of the Medicines Evaluation Board (MEB) on 1 June 2017.
Anthonius (Ton) de Boer new MEB chairman
01-06-2017 | 14:00
Prof. Ton de Boer is to take over as the new chairman of the Medicines Evaluation Board (MEB) as of 1 August 2017. This was...
MEB starts technical validation of electronic submissions as from 1 June 2017
29-05-2017 | 12:00
Submissions concerning human medicinal products must be submitted electronically to the Medicines Evaluation Board (MEB). As...
Confirmation of names for influenza strains
08-05-2017 | 11:00
The Medicines Evaluation Board (MEB) has confirmed the Dutch translation for the active substances for influenza strains for...
Health Care Inspectorate (IGZ) request to marketing authorisation holders: questionnaire for pharmacovigilance
18-04-2017 | 08:00
The Dutch Health Care Inspectorate (IGZ) has developed a risk model for pharmacovigilance to obtain more insight into the risks...
Policy for the national informed consent marketing authorisation application
14-04-2017 | 14:00
A company that wants to apply for a marketing authorisation for a medicinal product that is identical to another product that...
One step closer to less animal testing
20-03-2017 | 09:00
In the future, a part of animal testing for new medicines will no longer be necessary. In most cases, testing on one species of...
Retrospective MEB eDay 2017: Change in sight
17-03-2017 | 15:00
In order to respond to e-developments, it is important that the information provision by the Medicines Evaluation Board (MEB)...
Notification form medicine shortages and defects now also in English
15-02-2017 | 14:00
As of today, the notification form of the Medicine shortages and defects notification centre is now also available in English....
Science Day 2017 - Generic drugs in society: the regulator’s dilemma
13-02-2017 | 16:00
Trust, costs, safety and proper information are the words that regularly recurred during the 6th Science Day of the Medicines...
The Netherlands a candidate for future EMA location
17-01-2017 | 16:00
The Netherlands has submitted its candidacy as the country of choice for housing the European Medicines Agency (EMA). The EMA...
Santeon and MEB exchange information about prescription of medicinal products
13-01-2017 | 10:00
In the coming year, the Medicines Evaluation Board (MEB) and hospitals affiliated with Santeon will exchange anonymous...
Start of Medicine shortages and defects notification centre
02-01-2017 | 12:00
Today, the Medicine shortages and defects notification centre has been launched. The notification centre is located at the...